| ?? |
?? ?? |
CAS |
MF |
 |
XL413 (BMS-863233) |
1169562-71-3 |
C14H13Cl2N3O2 |
 |
NU 6027 |
220036-08-8 |
C11H17N5O2 |
 |
Ro 3306 |
872573-93-8 |
C18H13N3OS2 |
 |
SU 9516 |
377090-84-1 |
C13H11N3O2 |
 |
P276 |
920113-03-7 |
C21H21Cl2NO5 |
 |
ML167 |
1285702-20-6 |
C19H17N3O3 |
 |
?????? |
109581-93-3 |
C44H71NO13 |
 |
???????? |
50-18-0 |
C7H15Cl2N2O2P |
 |
Mycophenolate mofetil |
115007-34-6 |
C23H31NO7 |
 |
4,4'-propylenebis(piperazine-2,6-dione) |
21416-67-1 |
C11H16N4O4 |
 |
XL-388 |
1251156-08-7 |
C23H22FN3O4S |
 |
WAY-600 |
1062159-35-6 |
C28H30N8O |
 |
WYE-687 |
1062161-90-3 |
C28H32N8O3 |
![3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)-](/CAS/GIF/120964-45-6.gif) |
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)- |
120964-45-6 |
C12H15ClN4O3 |
 |
MM-102 |
1417329-24-8 |
C35H49F2N7O4 |
 |
EI1 |
1418308-27-6 |
C23H26N4O2 |
 |
UNC0379 |
1620401-82-2 |
C23H35N5O2 |
 |
MI-2 (Menin-MLL Inhibitor) |
1271738-62-5 |
C18H25N5S2 |
 |
LDN-193189 HCl |
1062368-62-0 |
C25H23ClN6 |
 |
ITF2357 |
732302-99-7 |
C24H30ClN3O5 |
 |
IKK Inhibitor III, BMS-345541 |
445430-58-0 |
C14H17N5 |
 |
MS436 |
1395084-25-9 |
C18H17N5O3S |
 |
K 02288 |
1431985-92-0 |
C20H20N2O4 |
 |
LDN212854 |
1432597-26-6 |
C25H22N6 |
 |
??????? |
99873-43-5 |
C11H14ClNO3 |
 |
Bikinin |
188011-69-0 |
C9H9BrN2O3 |
 |
NVP-HSP990(HSP990) |
934343-74-5 |
C20H18FN5O2 |
![4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione](/CAS/GIF/865854-05-3.gif) |
4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione |
865854-05-3 |
C19H14N2O2S |
 |
AT-13148 |
1056901-62-2 |
C17H16ClN3O |
 |
IM-12 |
1129669-05-1 |
C22H20FN3O2 |
![4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline](/CAS/GIF/1206711-16-1.gif) |
4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline |
1206711-16-1 |
C24H20N4O |
 |
Tubacin |
537049-40-4 |
C41H43N3O7S |
 |
PF-2545920 |
1292799-56-4 |
C25H20N4O |
 |
VER-50589 |
747413-08-7 |
C19H17ClN2O5 |
 |
SGC0946 |
1561178-17-3 |
C28H40BrN7O4 |
 |
AZD-2858 |
486424-20-8 |
C21H23N7O3S |
 |
XL888 |
1149705-71-4 |
C29H37N5O3 |
 |
CAY10603 |
1045792-66-2 |
C22H30N4O6 |
 |
OTX015 |
202590-98-5 |
C25H22ClN5O2S |
 |
Refametinib |
923032-37-5 |
C19H20F3IN2O5S |
 |
CEP 33779 |
1257704-57-6 |
C24H26N6O2S |
 |
MK8745 |
885325-71-3 |
C20H19ClFN5OS |
 |
SGC-CBP30 |
1613695-14-9 |
C28H33ClN4O3 |
 |
BroMosporine |
1619994-69-2 |
C17H20N6O4S |
 |
Nexturastat A |
1403783-31-2 |
C19H23N3O3 |
 |
SB269970 HCl |
261901-57-9 |
C18H28N2O3SHCl |
 |
SD-208 |
627536-09-8 |
C17H10ClFN6 |
![7-benzyl-10-(2-Methylbenzyl)-2,6,7,8,9,10-hexahydroiMidazo[1,2-a]pyrido[4,3-d]pyriMidin-5(3H)-one](/CAS/GIF/41276-02-2.gif) |
7-benzyl-10-(2-Methylbenzyl)-2,6,7,8,9,10-hexahydroiMidazo[1,2-a]pyrido[4,3-d]pyriMidin-5(3H)-one |
41276-02-2 |
C24H26N4O |
 |
S-?????(INCB018424) |
941685-37-6 |
C17H18N6 |
 |
TMP269 |
1314890-29-3 |
C25H21F3N4O3S |
![5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a]](/CAS/20150408/GIF/1062368-49-3.gif) |
5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a] |
1062368-49-3 |
C22H16N4O |
 |
Sb-742457 |
607742-69-8 |
C19H19N3O2S |
 |
VUF 10166 |
155584-74-0 |
C13H15ClN4 |
 |
UNC 669 |
1314241-44-5 |
C15H20BrN3O |
 |
Vinflunine Tartrate |
1201898-17-0 |
C49H60F2N4O14 |
 |
GNE 7915 |
1351761-44-8 |
C19H21F4N5O3 |
 |
P 22077 |
1247819-59-5 |
C12H7F2NO3S2 |
 |
5-Carboxy-8-hydroxyquinoline |
5852-78-8 |
C10H7NO3 |
 |
EHT1864 |
754240-09-0 |
C25H27F3N2O4S2HCl |
 |
TAK-700 |
426219-18-3 |
C18H17N3O2 |
 |
CYP3cide |
1390637-82-7 |
C26H32N8 |
 |
CEP-32496 (free base) |
1188910-76-0 |
C24H22F3N5O5 |
 |
ML-323 |
1572414-83-5 |
C23H24N6 |
 |
Mildronate dihydrate |
86426-17-7 |
C6H14N2O2.2H2O |
 |
AT-101 |
866541-93-7 |
C32H34O10 |
 |
BAY 87-2243 |
1227158-85-1 |
C26H26F3N7O2 |
 |
SP2509 |
1423715-09-6 |
C19H20ClN3O5S |
 |
Losmapimod (GW856553X) |
585543-15-3 |
C22H26FN3O2 |
 |
NSC 23766 (hydrochloride) |
1177865-17-6 |
C24H35N7 |
 |
AZ20 |
1233339-22-4 |
C21H24N4O3S |
 |
MK-2048 |
869901-69-9 |
C21H21ClFN5O4 |
 |
VE 822 |
1232416-25-9 |
C24H25N5O3S |
 |
Encorafenib (LGX818) |
1269440-17-6 |
C22H27ClFN7O4S |
 |
CCG-1423 |
285986-88-1 |
C18H13ClF6N2O3 |
 |
PF-04620110 |
1109276-89-2 |
C21H24N4O4 |
 |
Dolutegravir sodium |
1051375-19-9 |
C20H20F2N3NaO5 |
 |
????????(TKI258????) |
852433-84-2 |
C24H27FN6O4 |
 |
JIB-04 |
199596-05-9 |
C17H13ClN4 |
 |
CW069 |
1594094-64-0 |
C23H21IN2O3 |
 |
GNE-0877 |
1374828-69-9 |
C14H16F3N7 |
 |
GSK J4 HCl |
1373423-53-0 |
C24H27N5O2 |
 |
G-749 |
1457983-28-6 |
C25H25BrN6O2 |
 |
ADX-47273 |
851881-60-2 |
C20H17F2N3O2 |
 |
LGK-974 |
1243244-14-5 |
C23H20N6O |
 |
GNE-9605 |
1536200-31-3 |
C17H20ClF4N7O |
 |
VU 0364770 |
61350-00-3 |
C12H9ClN2O |
 |
N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine |
1380432-32-5 |
C25H30N6O |
 |
FGFR inhibitor |
848318-25-2 |
C18H15N2NaO4 |
 |
FLI-06 |
313967-18-9 |
C25H30N2O5 |
 |
WS6 |
1421227-53-3 |
C29H31F3N6O3 |
 |
BMH21 |
896705-16-1 |
C21H20N4O2 |
 |
MMP-2/MMP-9 INHIBITOR IV |
292605-14-2 |
C15H14O3S2 |
 |
ENMD-2076 (Tartrate) |
1291074-87-7 |
C21H25N7.x(C4H6O6) |
 |
LRRK2-kinase inhibitor |
1285515-21-0 |
C24H18FN3O2 |
 |
RO3280 |
1062243-51-9 |
C27H35F2N7O3 |
 |
IWP L6 |
1427782-89-5 |
C25H20N4O2S2 |
 |
IKK 16 |
873225-46-8 |
C28H29N5OS |
 |
b-AP15 |
1009817-63-3 |
C22H17N3O6 |
 |
Entospletinib (GS-9973) |
1229208-44-9 |
C23H21N7O |
 |
Z-PHE-DL-ALA-FLUOROMETHYLKETONE |
197855-65-5 |
C21H23FN2O4 |